Bon Natural Life (BON) Competitors $1.44 -0.04 (-2.70%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock BON vs. NMTR, PBLA, TRVN, PTPI, BIOR, HEPA, BPTSY, VRPX, VIRX, and NCNAShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include 9 Meters Biopharma (NMTR), Panbela Therapeutics (PBLA), Trevena (TRVN), Petros Pharmaceuticals (PTPI), Biora Therapeutics (BIOR), Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Viracta Therapeutics (VIRX), and NuCana (NCNA). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. Its Competitors 9 Meters Biopharma Panbela Therapeutics Trevena Petros Pharmaceuticals Biora Therapeutics Hepion Pharmaceuticals Biophytis Virpax Pharmaceuticals Viracta Therapeutics NuCana Bon Natural Life (NASDAQ:BON) and 9 Meters Biopharma (NASDAQ:NMTR) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment. Which has better valuation & earnings, BON or NMTR? Bon Natural Life has higher revenue and earnings than 9 Meters Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBon Natural Life$23.84M0.01$400KN/AN/A9 Meters BiopharmaN/AN/A-$43.77M-$3.46N/A Do institutionals and insiders hold more shares of BON or NMTR? 0.6% of Bon Natural Life shares are held by institutional investors. Comparatively, 22.3% of 9 Meters Biopharma shares are held by institutional investors. 26.5% of Bon Natural Life shares are held by company insiders. Comparatively, 2.4% of 9 Meters Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer BON or NMTR? In the previous week, Bon Natural Life's average media sentiment score of 0.00 equaled 9 Meters Biopharma'saverage media sentiment score. Company Overall Sentiment Bon Natural Life Neutral 9 Meters Biopharma Neutral Which has more risk & volatility, BON or NMTR? Bon Natural Life has a beta of -0.49, indicating that its share price is 149% less volatile than the S&P 500. Comparatively, 9 Meters Biopharma has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Is BON or NMTR more profitable? Bon Natural Life's return on equity of 0.00% beat 9 Meters Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Bon Natural LifeN/A N/A N/A 9 Meters Biopharma N/A -584.97%-159.45% SummaryBon Natural Life beats 9 Meters Biopharma on 5 of the 7 factors compared between the two stocks. Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeCONSM PD IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$245K$2.24B$8.20B$9.31BDividend YieldN/A4.44%3.14%4.03%P/E RatioN/A16.2520.9519.73Price / Sales0.013.434.07174.27Price / Cash0.1416.2916.7557.96Price / Book0.011.654.835.67Net Income$400K$103.54M$215.29M$257.79M7 Day Performance-5.26%-1.90%-0.13%0.52%1 Month Performance-1.37%-2.91%38.59%8.84%1 Year PerformanceN/A-14.88%14.04%14.18% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural Life0.5234 of 5 stars$1.44-2.7%N/AN/A$245K$23.84M0.00100Gap DownNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220PBLAPanbela Therapeutics0.2104 of 5 stars$0.21-22.3%N/A-33.5%$1.02MN/A0.006TRVNTrevena1.7081 of 5 stars$0.94-5.5%$5.00+434.6%-84.5%$897K$443K-0.0240Gap DownPTPIPetros Pharmaceuticals0.5629 of 5 stars$0.03-2.7%N/A-99.7%$888K$5.11M-0.0120Gap DownBIORBiora Therapeutics1.7837 of 5 stars$0.15+6.5%$23.00+15,664.2%-98.0%$660K$892K-0.01120Gap UpHEPAHepion Pharmaceuticals0.2561 of 5 stars$0.06-6.3%N/A-99.9%$656KN/A-0.0120Gap UpBPTSYBiophytisN/A$1.33-8.3%N/AN/A$467KN/A0.0030Gap DownVRPXVirpax Pharmaceuticals1.493 of 5 stars$0.35+7.2%$75.00+21,110.4%-98.7%$439KN/A0.007VIRXViracta Therapeutics2.0121 of 5 stars$0.01-18.5%$1.75+15,809.1%-98.2%$437KN/A-0.0120Gap DownNCNANuCana3.1826 of 5 stars$0.05-15.9%$25.00+49,700.8%-98.4%$360KN/A-0.0130Stock SplitHigh Trading Volume Related Companies and Tools Related Companies 9 Meters Biopharma Competitors Panbela Therapeutics Competitors Trevena Competitors Petros Pharmaceuticals Competitors Biora Therapeutics Competitors Hepion Pharmaceuticals Competitors Biophytis Competitors Virpax Pharmaceuticals Competitors Viracta Therapeutics Competitors NuCana Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BON) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BON Stock Alerts